Search

Author/Creator Okamoto, Rika

1. Design and rationale of the EVOCATION trial: A prospective, randomized, exploratory study comparing the effect of evolocumab on coronary microvascular function after percutaneous coronary intervention in patients with stable coronary artery disease. Issue 1 (January 2022)

Authors:
Asakura, Masanori; Hibi, Kiyoshi; Shimizu, Wataru; Fujii, Kenshi; Suwa, Satoru; Okumura, Yasuo; Mano, Toshiaki; Igeta, Masataka; Okamoto, Rika; Ishihara, Masaharu
Journal:
Journal of cardiology
Issue:
Volume 79:Issue 1(2022)
Page Start:
105
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn's disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled, dose–response trial. Issue 1 (31st May 2018)

Authors:
Otagiri, Shinsuke; Ohnishi, Shunsuke; Miura, Arisa; Hayashi, Hiroshi; Kumagai, Izumi; Ito, Yoichi M; Katsurada, Takehiko; Nakamura, Shiro; Okamoto, Rika; Yamahara, Kenichi; Cho, Kyu Yong; Isoe, Toshiyuki; Sato, Norihiro; Sakamoto, Naoya
Journal:
BMJ open gastroenterology
Issue:
Volume 5:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial. Issue 7 (9th July 2019)

Authors:
Yamahara, Kenichi; Hamada, Akiko; Soma, Toshihiro; Okamoto, Rika; Okada, Masaya; Yoshihara, Satoshi; Yoshihara, Kyoko; Ikegame, Kazuhiro; Tamaki, Hiroya; Kaida, Katsuji; Inoue, Takayuki; Ohsugi, Yuko; Nishikawa, Hiroki; Hayashi, Hiroshi; Ito, Yoichi M; Iijima, Hiroaki; Ohnishi, Shunsuke; Hashimot...
Journal:
BMJ open
Issue:
Volume 9:Issue 7(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗